Ibrutinib Blood Cancer Imbruvica 140 Mg

Product Description

This medication is used to treat certain cancers(such as mantle cell or marginal zone lynphoma,chroniclymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of.Ibrutinib is a type of drug called a kinase inhibitor. Ibrutinib may kill cancer cells or stop them from growing by blocking a type of protein called a kinase that helps lymphoma cells live and grow. Rituximab is a monoclonal antibody that may interfere with the ability of lymphoma cells to grow and spread.Imbruvica could be could be taken as a dose once a day as either a 560 mg or four 140 mg capsules.Take one 560 mg imbruvica tabket my mouth ,at thesame time each day with a glass of water.imbutinib treat cancers like antle cell lymphoma.chronic lymphocytic leukaemia (CLL)Waldenstrom's macroglobulinaemia.Ibrutinib has its sides efffects which includes

Belching.decreased appetite.difficulty having a bowel movement.heartburn or indigestion.muscle stiffness or spasms.small red or purple spots on the skin.stomach discomfort, upset, or pain.swelling or inflammation of the mouth